<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Reyes SB</submitter><funding>NINDS NIH HHS</funding><funding>NCI NIH HHS</funding><pagination>474-82</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC3571870</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>24(4)</volume><pubmed_abstract>The malignant brain cancer glioblastoma multiforme (GBM) displays invasive growth behaviors that are regulated by extracellular cues within the neural microenvironment. The adhesion and signaling pathways that drive GBM cell invasion remain largely uncharacterized. Here we use human GBM cell lines, primary patient samples, and preclinical mouse models to demonstrate that integrin αvβ8 is a major driver of GBM cell invasion. β8 integrin is overexpressed in many human GBM cells, with higher integrin expression correlating with increased invasion and diminished patient survival. Silencing β8 integrin in human GBM cells leads to impaired tumor cell invasion due to hyperactivation of the Rho GTPases Rac1 and Cdc42. β8 integrin coimmunoprecipitates with Rho-GDP dissociation inhibitor 1 (RhoGDI1)</pubmed_abstract><journal>Molecular biology of the cell</journal><pubmed_title>αvβ8 integrin interacts with RhoGDI1 to regulate Rac1 and Cdc42 activation and drive glioblastoma cell invasion.</pubmed_title><pmcid>PMC3571870</pmcid><funding_grant_id>R01 NS059876</funding_grant_id><funding_grant_id>R01NS059876</funding_grant_id><funding_grant_id>P50 CA127001</funding_grant_id><funding_grant_id>R01NS078402</funding_grant_id><funding_grant_id>R01 NS078402</funding_grant_id><funding_grant_id>P50CA127001</funding_grant_id><funding_grant_id>R01 NS062829</funding_grant_id><pubmed_authors>McCarty JH</pubmed_authors><pubmed_authors>Aldape KD</pubmed_authors><pubmed_authors>Tolias KF</pubmed_authors><pubmed_authors>Narayanan AS</pubmed_authors><pubmed_authors>Lee HS</pubmed_authors><pubmed_authors>Tchaicha JH</pubmed_authors><pubmed_authors>Reyes SB</pubmed_authors><pubmed_authors>Lang FF</pubmed_authors></additional><is_claimable>false</is_claimable><name>αvβ8 integrin interacts with RhoGDI1 to regulate Rac1 and Cdc42 activation and drive glioblastoma cell invasion.</name><description>The malignant brain cancer glioblastoma multiforme (GBM) displays invasive growth behaviors that are regulated by extracellular cues within the neural microenvironment. The adhesion and signaling pathways that drive GBM cell invasion remain largely uncharacterized. Here we use human GBM cell lines, primary patient samples, and preclinical mouse models to demonstrate that integrin αvβ8 is a major driver of GBM cell invasion. β8 integrin is overexpressed in many human GBM cells, with higher integrin expression correlating with increased invasion and diminished patient survival. Silencing β8 integrin in human GBM cells leads to impaired tumor cell invasion due to hyperactivation of the Rho GTPases Rac1 and Cdc42. β8 integrin coimmunoprecipitates with Rho-GDP dissociation inhibitor 1 (RhoGDI1)</description><dates><release>2013-01-01T00:00:00Z</release><publication>2013 Feb</publication><modification>2025-04-19T17:21:08.722Z</modification><creation>2019-03-27T01:04:47Z</creation></dates><accession>S-EPMC3571870</accession><cross_references><pubmed>23283986</pubmed><doi>10.1091/mbc.E12-07-0521</doi></cross_references></HashMap>